Literature DB >> 16248911

Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective.

Krista Lisdahl Medina1, Paula K Shear, Kevin Corcoran.   

Abstract

Ecstasy (MDMA) is a popular drug that can act as a selective serotonin neurotoxin in several species. The goal of the present study was to examine the relationship between ecstasy exposure and cognitive functioning after controlling for other drug use and demographic variables. Furthermore, we assessed whether gender was a moderator of the relationship between cognitive functioning and ecstasy use. Data were collected from 31 men and 34 women with a wide range of ecstasy use (17 marijuana users with no ecstasy use and 48 ecstasy users ranging from low to heavy use). Participants were interviewed and administered a battery of neuropsychological tests. The primary finding was that ecstasy exposure was significantly related to poorer verbal learning and memory ability in a dose-dependent manner, while no such relationship was observed between ecstasy exposure and executive functioning or attentional ability. Gender was found to significantly moderate the relationship between ecstasy consumption and design fluency. These results suggest primary memory dysfunction among abstinent recreational ecstasy users. This finding is consistent with reports of hippocampal vulnerability, particularly among heavy users.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16248911     DOI: 10.1017/S1355617705050915

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  12 in total

1.  Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry.

Authors:  Krista Lisdahl Medina; Alecia D Schweinsburg; Mairav Cohen-Zion; Bonnie J Nagel; Susan F Tapert
Journal:  Neurotoxicol Teratol       Date:  2006-12-12       Impact factor: 3.763

2.  Increased marijuana use and gender predict poorer cognitive functioning in adolescents and emerging adults.

Authors:  Krista M Lisdahl; Jenessa S Price
Journal:  J Int Neuropsychol Soc       Date:  2012-05-22       Impact factor: 2.892

3.  Prospective memory functioning among ecstasy/polydrug users: evidence from the Cambridge Prospective Memory Test (CAMPROMPT).

Authors:  Florentia Hadjiefthyvoulou; John E Fisk; Catharine Montgomery; Nikola Bridges
Journal:  Psychopharmacology (Berl)       Date:  2011-02-08       Impact factor: 4.530

Review 4.  Differential effects of ecstasy on short-term and working memory: a meta-analysis.

Authors:  Claire E Nulsen; Allison M Fox; Geoffrey R Hammond
Journal:  Neuropsychol Rev       Date:  2010-02-16       Impact factor: 7.444

5.  Anxiety, depression, and behavioral symptoms of executive dysfunction in ecstasy users: contributions of polydrug use.

Authors:  Krista Lisdahl Medina; Paula K Shear
Journal:  Drug Alcohol Depend       Date:  2006-10-30       Impact factor: 4.492

6.  Serotonin transporter gene moderates associations between mood, memory and hippocampal volume.

Authors:  Jenessa S Price; Judith Strong; James Eliassen; Tim McQueeny; Megan Miller; Claudia B Padula; Paula Shear; Krista Lisdahl
Journal:  Behav Brain Res       Date:  2012-12-21       Impact factor: 3.332

7.  The influence of genetic and environmental factors among MDMA users in cognitive performance.

Authors:  Elisabet Cuyàs; Antonio Verdejo-García; Ana Beatriz Fagundo; Olha Khymenets; Joan Rodríguez; Aida Cuenca; Susana de Sola Llopis; Klaus Langohr; Jordi Peña-Casanova; Marta Torrens; Rocío Martín-Santos; Magí Farré; Rafael de la Torre
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

8.  Ecstasy exposure & gender: examining components of verbal memory functioning.

Authors:  Jenessa S Price; Paula Shear; Krista M Lisdahl
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

9.  5-HTTLPR Genotype Moderates the Effects of Past Ecstasy Use on Verbal Memory Performance in Adolescent and Emerging Adults: A Pilot Study.

Authors:  Natasha E Wright; Judith A Strong; Erika R Gilbart; Skyler G Shollenbarger; Krista M Lisdahl
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

10.  Gender differences in subjective discontinuation symptoms associated with ketamine use.

Authors:  Wen-Yin Chen; Ming-Chyi Huang; Shih-Ku Lin
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.